Patient-informed clinical trial development with Victoria DiBiaso, VP & Global Head Patient Informed Development & Health Value Translation at Sanofi

Today’s episode features Victoria DiBiaso from Sanofi. Victoria provides a detailed analysis of patient-informed development and the critical importance of diversity and inclusion in clinical trials. With her unique perspective stemming from her nursing background, she explains the significance of patient-centric trials and the future of healthcare.  Throughout the episode, Victoria elaborates on effective communication with patient communities, the significance of trust-building, and how understanding social determinants of health can aid in forging strong relationships with patient advisors. The episode further explores the world of drug development, from considering patient-relevant endpoints to health scales and label opportunities.    Topics Discussed:  (00:00:00) Introduction (00:00:51) Victoria’s background and how she ended up in her current role  (00:02:32) An explanation of patient-informed development  (00:03:48) The meaning of patient centricity  (00:06:13) Stumbling blocks to patient centricity  (00:08:14) What cross-industry collaboration is like  (00:09:41) Cross-industry collaboration milestones  (00:12:07) The new voice Victoria wants to bring forward  (00:16:56) How the new programs will fit into patients’ lives  (00:18:48) How to talk about clinical trials in language patients want to hear  (00:19:53) Important factors in implementing patient-centric solutions in clinical trial programs  (00:21:24) Victoria’s thinking about what parts of patient disease strategy are shareable and standardizable  (00:23:28) What the future of patient-centric clinical trials looks like  (00:25:16) What modern patient recruitment means   (00:26:53) How Victoria would change clinical trials overnight if she had a magic wand  (00:29:44) How to learn more about what Victoria is doing  Links:   Victoria DiBiaso